Medical College of Wisconsin
CTSIResearch InformaticsREDCap

MEK inhibitor-based therapy in metastatic pancreatic adenocarcinoma with KRAS G12R alteration. Clin Oncol 43, 2025 (suppl 4; abstr 725), ASCO Gastrointestinal Cancer symposium, Poster Presentation; San Francisco, January 2025

Date

01/27/2025

Author List

Auckley E, Ying G, Yohay S, Aldakkak M, Thalji SZ, Vakili P, Grahl J, Mayer B, Shahjehan F, Low SK, Evans DB, Christians KK, Seo YD, Erickson B, Hall WA, McFall T, Kurzrock R, George B, Kamgar M

Author

Mandana Kamgar MPH, MD Associate Professor in the Medicine department at Medical College of Wisconsin